BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Clinical trial NCT03861936 · COMPLETED

Trial details

NCT number: NCT03861936
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Masseter Muscle Prominence

Start date: 2019-05-16
Primary completion: 2020-04-03
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.